Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 11.45 | -16.67 |
PEG Ratio (TTM) | 0.11 | -5.49 |
P/S Ratio (TTM) | N/A | 37.47 |
P/B Ratio (TTM) | 1.33 | 5.86 |
P/FCF Ratio (TTM) | -2,166.59 | -148.99 |
Price to 5YR AVG Earnings Ratio | N/A | -33.81 |
Price to 5YR AVG FCF Ratio | N/A | -1.26 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 11.13% | 284.65% |
ROE (TTM) | 11.93% | -4,181.05% |
Net Profit Margin (TTM) | N/A | -1,000.23% |
ROIC 5YR AVG | N/A | -16.06% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 30.12% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | 33.31% | N/A | N/A |
Cash Flow | -66.55% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.61 | 4.92 |
Quick Ratio (TTM) | 0.61 | 4.89 |
D/E Ratio (TTM) | N/A | 1.28 |
Interest Coverage (TTM) | 0.02 | -11.13 |
Piotroski F-Score | 2 | 3 |
Altman Z-Score | 19.26 | 20.79 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 887.85% |